Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis.

E R R A T U M

Erratum to: Can We Identify Patients with High Risk

of Osteoarthritis Progression Who Will Respond to Treatment?

A Focus on Epidemiology and Phenotype of Osteoarthritis

Olivier Bruye`re

_{Cyrus Cooper}

_{Nigel Arden}

_{Jaime Branco}

Maria Luisa Brandi

_{Gabriel Herrero-Beaumont}

_{Francis Berenbaum}

Elaine Dennison

_{Jean-Pierre Devogelaer}

_{Marc Hochberg}

John Kanis

_{Andrea Laslop}

_{Tim McAlindon}

_{Susanne Reiter}

Pascal Richette

_{Rene´ Rizzoli}

_{Jean-Yves Reginster}

Published online: 27 March 2017

Ó Springer International Publishing Switzerland 2017

Erratum to: Drugs Aging (2015) 32:179–187

DOI 10.1007/s40266-015-0243-3

In the Original publication the affiliation for J. Kanis was

incorrectly published.

This previously read: WHO Collaborating Centre for

Metabolic Bone Diseases, University of Sheffield Medical

School, Sheffield, UK.

Should read: Centre for Metabolic Bone Diseases,

University of Sheffield Medical School, Sheffield, UK.

The online version of the original article can be found under doi:10.1007/s40266-015-0243-3.

& Olivier Bruye`re

olivier.bruyere@ulg.ac.be

1 _{Department of Public Health, Epidemiology and Health}

Economics, University of Lie`ge, CHU Sart-Tilman B23, 4000 Lie`ge, Belgium

2 _{MRC Lifecourse Epidemiology Unit and NIHR Nutrition}

Biomedical Research Centre, University of Southampton, Southampton, UK

3 _{Oxford NIHR Musculoskeletal Biomedical Research Unit,}

University of Oxford, Oxford, UK

4 _{CEDOC, Department of Rheumatology, Faculdadede}

Cieˆncias Me´dicas, Universidade Novade Lisboa, CHLO, EPE, Hospital Egas Moniz, Lisbon, Portugal

5 _{Metabolic Bone Unit, Department of Surgery and}

Translational Medicine, University of Florence, Florence, Italy

6 _{Department of Rheumatology, Bone and Joint Research Unit,}

IIS-Fundacio´n Jime´nez Dı´az, UAM, Fundacio´n Jime´nez Dı´az, Madrid, Spain

7 _{Department of Rheumatology, AP-HP, Saint-Antoine}

Hospital, Pierre and Marie Curie University, Paris, France

8 _{Department of Rheumatology, Saint-Luc University Hospital,}

Universite´ Catholique de Louvain, Brussels, Belgium

9 _{Departments of Medicine and Epidemiology and Public}

Health, University of Maryland School of Medicine, Baltimore, MD, USA

10 _{Centre for Metabolic Bone Diseases, University of Sheffield}

Medical School, Sheffield, UK

11 _{Scientific Office, Austrian Agency for Health and Food}

Safety (AGES), Vienna, Austria

12 _{Division of Rheumatology, Tufts Medical Center, Boston,}

MA, USA

13 _{Bundesinstitut fu¨r Arzneimittel und Medizinprodukte, Bonn,}

Germany

14 _{Universite´ Paris 7, UFR me´dicale, Assistance}

Publique-Hoˆpitaux de Paris, Hoˆpital Lariboisie`re, Fe´de´ration de Rhumatologie, Paris Cedex, France

15 _{Division of Bone Diseases, Geneva University Hospital and}

Faculty of Medicine, Geneva, Switzerland Drugs Aging (2017) 34:411